Pregled bibliografske jedinice broj: 1224474
Systematic Review with Trial Sequential Analysis of Prophylactic Antibiotics for Acute Pancreatitis
Systematic Review with Trial Sequential Analysis of Prophylactic Antibiotics for Acute Pancreatitis // Antibiotics, 11 (2022), 9; 1191, 14 doi:10.3390/antibiotics11091191 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1224474 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Systematic Review with Trial Sequential Analysis of
Prophylactic Antibiotics for Acute Pancreatitis
Autori
Poropat, Goran ; Goričanec, Karla ; Lacković, Alojzije ; Kresović, Andrea ; Lončarić, Antun ; Marušić, Martina
Izvornik
Antibiotics (2079-6382) 11
(2022), 9;
1191, 14
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
anti-bacterial agents ; meta-analysis ; pancreatic necrosis ; randomized controlled trials ; sepsis
Sažetak
Background/Objectives: Prophylactic antibiotics (PAB) are being still widely used for treatment of acute pancreatitis (AP) despite trials showing no firm evidence of efficacy. We aimed to evaluate effects of PAB for AP in a meta-analysis and the need for further research by trial sequential analysis (TSA). Methods: Medline, Scopus and Web of Science were searched for randomized clinical trials. Primary outcomes were all infections and mortality. Secondary outcomes comprised infected pancreatic necrosis (IPN), specific infections, organ failure, surgical interventions, and length of hospital stay. Results: Twenty-one trials with 1383 pts were included. PAB were received by 703 pts, while 680 were controls. Mortality was similar with RR 0.85 (95% CI 0.66–1.10). Infections were significantly reduced (RR 0.60 ; 95% CI 0.49–0.74), mainly due to decreased risk of sepsis (RR 0.43 ; 95% CI 0.25–0.73) and urinary tract infections (RR 0.46 ; 95% CI 0.25–0.86). No significant reduction for IPN was shown (RR 0.81 ; 95% CI 0.63–1.04). Length of hospital stay was diminished by MD −6.65 (95% CI −8.86 to −4.43) days. TSA for all infections showed that the cumulative Z score crossed both conventional and monitoring boundaries at 526 pts from a heterogeneity-corrected required information size of 1113 pts based on a 40% incidence of infections in the control group, RRR of 30%, alpha 5%, beta 20%, and heterogeneity 56%. Conclusions: PABs decrease the rate of infections in AP, mainly due to RRR of extra-pancreatic infections, requiring no further research. No significant effect is shown on IPN and mortality, although firmer evidence is needed.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
--uniri-biomed-18-154 - Primjena balansiranih kristaloidnih otopina u ranoj fazi liječenja akutnog pankreatitisa (Poropat, Goran) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka,
Sveučilište u Rijeci
Profili:
Goran Poropat
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus